Microbiome TOPOSCORE Does Not Predict Melanoma Response to Immunotherapy Re-Induction
An exploratory analysis of the phase II PROMIT trial found that gut microbiome TOPOSCORE classifications failed to predict treatment outcomes ...
Tag: PROMIT trial
POPULAR NEWS
-
Four Social Support Profiles Emerge Among Migrant Older Adults, Study Finds
-
Younger Alzheimer’s patients carry heavier, faster-spreading tau burden, PET study finds
-
Electric toothbrush generates its own power to fight plaque bacteria
-
ASPM mutations derail human neural stem cells and explain microcephaly sensitivity